Amicures Research Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.02 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.11 M
About Amicures Research
Amicures Research Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2013 and has a history of 11 years and six months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.02 M.
The company currently has active open charges totaling ₹1.11 M.
Pankaj Kumar, Mamta Choudhary, Era Jain, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100GJ2013PTC076425
- Company No.
076425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Healthcare
Who are the key members and board of directors at Amicures Research?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Kumar  | Director | 14-Jun-2018 | Current |
| Era Jain | Director | 26-Oct-2020 | Current |
| Pankaj Kumar | Director | 14-Aug-2013 | Current |
| Mamta Choudhary | Director | 14-Aug-2013 | Current |
Financial Performance of Amicures Research.
Amicures Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amicures Research?
In 2017, Amicures Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dwa Herbals Private LimitedMamta Choudhary and Sushil Kumar are mutual person
Charges (Loans)
Open Charges
₹1.11 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
- State Bank Of India : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2020 | State Bank Of India | ₹0.11 M | Open |
| 21 Jun 2019 | Others | ₹1.00 M | Open |
How Many Employees Work at Amicures Research?
Unlock and access historical data on people associated with Amicures Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amicures Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amicures Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.